drugset / Trial / NCT06687759

A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)

NCT06687759

Phase 1 Completed 8 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to learn what happens to calderasib in a healthy person's body over time and how it is cleared from the body.

Timeline

Start
2024-06-26
Primary completion
2024-08-07
Completion
2024-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Calderasib Unknown Oral

Indications

No indication recorded.